Guidelines
The 2013 update to the 2012 New Zealand Primary Care Handbook guidelines on cardiovascular and diabetes risk assessment can be found here: www.health.govt.nz/system/files/documents/publications/cardiovascular-disease-risk-assessment-updated-2013-dec13.pdf.
Specific advice for people with diabetes is outlined in the New Zealand Primary Care Handbook (NZGG, 2012) here: www.health.govt.nz/system/files/documents/publications/nz-primary-care-handbook-2012.pdf.
The Cardiovascular and Diabetes Risk Assessment guidelines (2013) can be found here: www.health.govt.nz/system/files/documents/publications/cardiodiabetesriskassessment6dec13.pdf and state the following:
‘Relative risk reductions are more or less constant across the spectrum of combined risk. The higher the combined risk, the larger the absolute benefit of treating one or more risk factors. The majority of patients with:
an estimated five-year combined CVD risk below 10 percent can generally be well-managed without drug treatment
an estimated five-year combined CVD risk between 10 percent and 20 percent will benefit from shared decision-making about the benefits and harms of blood pressure (BP) and lipid lowering drugs
a combined CVD risk over 20 percent, including patients with a personal history of CVD, are likely to benefit significantly from blood pressure lowering, lipid-lowering and antiplatelet medication, over and above intensive non-pharmacological interventions.’
Dostları ilə paylaş: | 
